The Sumaira Foundation is a 501(c)(3) organization focused on improving the lives of those affected by neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). It provides education, community support, and advocacy to enhance understanding and treatment options for these rare neuroimmune conditions.
2014
47-2398246
$457.1 thousand
Overall Score
43
34
/100
Program Expense Ratio
76.19%
10
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.4905
8
/20
Working Capital Ratio
0.1697
4
/20
Fundraising Efficiency
1.605
10
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 1.481M | 101.60% |
| Program Services | 0 | 0.00% |
| Investment Income | 0 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 1.458M | 100.00% |
Med Research
Neurological ResearchMed Research
Neurological ResearchMed Research
Neurological ResearchMed Research
Neurological ResearchMed Research
Neurological Research